iRhythm Technologies Inc (IRTC)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account
Sell

$133.75

Buy

$136.19

arrow-up$1.01 (+0.75%)

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
Prices updated at 07 May 2025, 22:54 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Abhijit Y. Talwalkar
CEO
Mr. Quentin S. Blackford
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
2,000
Head office
699 8th Street
San Francisco
United States
94103
mobile
+1 415 632-5700
letter
investors@irhythmtech.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Mojdeh Poul
Independent Director
0.06m--0.22m-
Mr. Abhijit Y. Talwalkar
Chairman of the Board
0.11m--0.27m-
Mr. Mark J. Rubash
Independent Director
0.07m--0.23m-
Dr. Ralph Snyderman,M.D.
Independent Director
0.06m--0.22m-
Mr. Bruce G. Bodaken
Independent Director
0.07m--0.23m-
Ms. Karen L. Ling
Independent Director
0.07m--0.22m-
Mr. Quentin S. Blackford
Director, President and Chief Executive Officer
0.74m--9.34m-
Mr. Brian B. Yoor
Independent Director
0.06m--0.22m-
Dr. Cathleen Noel Bairey Merz, M.D.
Independent Director
0.06m--0.22m-
Mr. Chad Patterson
Chief Commercial Officer
0.52m--3.64m-
Ms. Sumi Shrishrimal
Executive Vice President and Chief Risk Officer
-----
Mr. Daniel G. Wilson
Chief Financial Officer
0.46m--2.54m-
Mr. Patrick M. Murphy
Chief Business Officer and Chief Legal Officer
0.51m--3.00m-
Mr. Marc Rosenbaum
Senior Vice President, Finance and Chief Accounting Officer
-----
Dr. Minang Turakhia, M.D.,M.S.
Chief Medical Officer, Chief Scientific Officer and Executive Vice President, Product Innovation
0.51m--3.32m-
Mr. Mervin Smith
Executive Vice President, Business Operations
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Sands Capital Management, LLC3,176,7020.84757105381149.64037230 Apr 20259.95
Vanguard Group Inc3,136,3700.00493184420.59148330 Apr 20259.82
Artisan Partners LP2,780,259-2780259-30 Apr 20258.88
Mackenzie Investments2,763,8840.11784134405094.66247530 Apr 20258.66
Artisan Partners Limited Partnership2,762,7340.37476-17525-0.63033730 Apr 20258.65

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
04 Nov 2024-Mr. Abhijit Y. Talwalkar75.16500,86618,941--
15 Sep 2024-Mr. Daniel G. Wilson--36,216--
09 Aug 2024-Mr. Brice Bobzien70.3496,50624,428--
02 Aug 2024-Mr. Mervin Smith74.6651,36610,360--
02 Jul 2024-Mr. Minang Turakhia105.65148,33327,255--
03 Jun 2024-Ms. Sumi Shrishrimal88.91100,55723,298--
03 Jun 2024-Mr. Marc Rosenbaum88.9145,3448,174--
31 May 2024-Mr. Quentin S. Blackford74.9820,994176,074--
04 Nov 2024-Mr. Quentin S. Blackford77.411,249,784159,929--
02 Aug 2024-Mr. Chad Patterson74.66224,87637,133--
31 May 2024-Mr. Chad Patterson74.9820,99440,145--
29 May 2024-Mr. Abhijit Y. Talwalkar--12,277--
29 May 2024-Mr. Mark J. Rubash--12,430--
29 May 2024-Dr. Ralph Snyderman,M.D.--11,930--
29 May 2024-Mr. Bruce G. Bodaken--11,280--
29 May 2024-Ms. Karen L. Ling--8,210--
29 May 2024-Mr. Brian B. Yoor--4,240--
29 May 2024-Dr. Cathleen Noel Bairey Merz--7,615--
29 May 2024-Ms. Mojdeh Poul--4,240--
04 Mar 2024-Mr. Quentin S. Blackford111.14469,122175,794--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.